EuroPCR 2025 brought together over 12,000 professionals in interventional cardiovascular medicine from across the globe for four days of innovation, education, and collaboration at the Palais des Congrรจs in Paris. Organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the event provided an unparalleled platform for cardiologists, surgeons, radiologists, nurses, and allied healthcare professionals to explore the latest advancements in cardiovascular care.
Our team was proud to be part of this influential gathering, with representation from our founders Katharina Kiss and Siegfried Einhellig, and key team members including Roswitha Wolfram, Guilherme Agreli, Mirko Einhellig, Ana Milec, Vincenzo Mancuso, Cheila Penteado, Andrej Petrovski, Hugo Rodrigues, Robert Rรถssler, and Juan Serrano Moreno.
A highlight of our participation was the expert panel on โTranscatheter Tricuspid Valve Replacement in the Real World: Current Data and Outcomes,โ held on Wednesday, 21 May. Dr. Luis Manuel Domรญnguez Rodrรญguez presented compelling real-world data on the efficacy and safety of TricValve bicaval implantation in patients with pacemakers, offering valuable insights for clinicians exploring next-generation tricuspid therapies.
Our booth served as a dynamic hub for hands-on learning and meaningful conversation, featuring:
- Live expert Q&As
- Product samples of the TricValve system
- Clinical results & procedural videos
- Real-world insights into transcatheter tricuspid therapies
This space was designed to facilitate in-depth dialogue with healthcare professionals seeking cutting-edge solutions in tricuspid valve care and to showcase the people and passion behind our innovations in minimally invasive cardiology.
Weโre grateful for the opportunity to connect with the global interventional community and contribute to shaping the future of cardiovascular care together.
